Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Clasificación en acciones #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Precio por acción
$4.00
Última sincronización: 2026-08-20
Capitalización bursátil
$75.37M
Cambio (1 día)
0.00%
Cambio (1 año)
12.99%
País
US
Comercio RetinalGenix Technologies Inc. (RTGN)

Categoría

Ratio P/B de RetinalGenix Technologies Inc. (RTGN)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de RetinalGenix Technologies Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de RetinalGenix Technologies Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
- -
DE